Lee Nadler M.D.
Virginia and D.K. Ludwig Professor for Cancer Research, Department of Medicine, Harvard Medical School
Senior Vice President, Experimental Medicine, Dana-Farber Cancer Institute
Chief, Division of Medical Oncology, Brigham and Women's Hospital
Contact Info
Lee Nadler
Dana-Farber Cancer Institute
44 Binney Street
Boston, MA, 02115
Mailstop: Smith 339
Phone: 6176323331
Fax: 6176323541
lee_nadler@dfci.harvard.edu
Phone: 617.632.4932
Fax: 6176323770
valerie_russo@dfci.harvard.edu
Dana-Farber Cancer Institute
44 Binney Street
Boston, MA, 02115
Mailstop: Smith 339
Phone: 6176323331
Fax: 6176323541
lee_nadler@dfci.harvard.edu
Assistant
Valerie RussoPhone: 617.632.4932
Fax: 6176323770
valerie_russo@dfci.harvard.edu
DF/HCC Program Affiliation
Member, Leukemia ProgramMember, Lymphoma and Myeloma Program
Member, Cancer Immunology Program
DF/HCC Associations
Institutional Representative for DFCI, Membership CommitteeMember, Clinical Science Coordinating Committee
Deputy Associate Director, Planning and Evaluation, EC
Deputy Associate Director, Clinical Science, EC
Institutional Representative for DFCI, Executive Committee
Publications
- Vonderheide RH, Hahn WC, Schultze JL, Nadler LM. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity 1999 Jun; 10(6):673-9
PMID: 10403642 - Guinan EC, Boussiotis VA, Neuberg D, Brennan LL, Hirano N, Nadler LM, Gribben JG. Transplantation of anergic histoincompatible bone marrow allografts. N Engl J Med 1999 Jun 3; 340(22):1704-14
PMID: 10352162
